Reconsidering S100B: Why it is time to abandon its use in detecting disease recurrence in stage III melanoma patients

M R Jansen, S Caini, I Stanganelli, L B Been, B L van Leeuwen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
92 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Reconsidering S100B: Why it is time to abandon its use in detecting disease recurrence in stage III melanoma patients'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases